MG
AVNS

Mather Group’s Avanos Medical AVNS Stock Holding History

Mather Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$199 Hold
8
– – ﹤0.01% 1865
2026
Q1 		$112 Buy
+8
New +$108 ﹤0.01% 1865
2025
Q4 		– Sell
-8
Closed -$92 – 723
2025
Q3 		$92 Buy
+8
New +$94 ﹤0.01% 1685
2025
Q2 		– Sell
-8
Closed -$115 – 691
2025
Q1 		$115 Sell
8
-8
-50% -$125 ﹤0.01% 1757
2024
Q4 		$255 Hold
16
– – ﹤0.01% 1688
2024
Q3 		$384 Hold
16
– – ﹤0.01% 1632
2024
Q2 		$319 Buy
+16
New +$312 ﹤0.01% 2100

Other funds holding AVNS

SRC
Samson Rock Capital London, United Kingdom $45.6M AUM 86.17% 1-Year Est. Return
CIEC
Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
SIM
SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Mather Group's AVNS Position: Q2 2026 in Review

Mather Group held its Avanos Medical (AVNS) position steady in Q2 2026 at 8 shares worth $199. The position accounts for ﹤0.01% of the portfolio, ranked #1865.

Mather Group first reported a position in AVNS in Q2 2024 and has held it in 7 quarters since. The position peaked at $384 in Q3 2024. 73 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Mather Group held 8 shares of Avanos Medical worth $199 as of Q2 2026.
  • Mather Group left its Avanos Medical share count unchanged in Q2 2026.
  • Avanos Medical made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1865 holding.
  • Mather Group first reported a position in Avanos Medical in Q2 2024 and has held it in 7 quarters since.
  • Mather Group's Avanos Medical position peaked at $384 in Q3 2024.
  • 73 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.